Infectious Diseases
June 14, 2022
ROCHESTER, Minn. — Mayo Clinic researchers studied the outcomes of 483 high-risk patients treated for COVID-19 with a five-day oral regimen of nirmatrelvir and ritonavir,[...]
January 21, 2013
January 11, 2013
January 10, 2013
January 10, 2013
January 10, 2013
January 3, 2013
December 3, 2012
November 27, 2012
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community